Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT03860805
Active, not recruiting Not applicable

SALpingectomy for STERilization (SALSTER)

NCT03860805 · tracked via the Priya Life Science Sweden tracker
Sponsor
Göteborg University
Phase
Not applicable
Started
2019-04-03
Last updated
2025-01-17

Condition(s) studied

Sterilization TubalSalpingectomyLaparoscopyOvarian Reserve

Investigational drug(s) / intervention(s)

Laparoscopic tubal ligationLaparoscopic bilateral salpingectomy

Laparoscopic tubal ligation: Laparoscopic tubal ligation

Laparoscopic bilateral salpingectomy: Laparoscopic bilateral salpingectomy

Study summary

The SALSTER study is a register-based randomized clinical trial (R-RCT) that examines if laparoscopic salpingectomy instead of tubal ligation, as a contraceptive method, has no increased risk for complications and has no negative impact on ovarian function.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
49 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Planned laparoscopic sterilization * Willing to be randomized Exclusion Criteria: * Women older than 49 * Not understanding the oral or written study information * Previous malignancy involving radiation, chemotherapy or endocrine treatment affecting ovarian function

Primary outcome measure(s)

  • Complications — Eight weeks post-operatively
    Complication according to the Clavien-Dindo classification or specific questions on complications in GynOp Register (Swedish National Quality Register of Gynecological Surgery). Binary data.
  • Age at menopause — Twenty years
    Determined from questionnaires on bleeding pattern in GynOp. Continuous data.

Trial sites (1)

FacilityCityRegionStatus
Sahlgrenska University Hospital Gothenburg Sweden

More Göteborg University trials in Sweden

Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction Active, not recruiting
The Effects of Nitrate-Rich Mouthwash on Vascular Tone Starting soon
Sahlgrenska Cardiomyopathy Project Enrolling by invitation
Effects of and Exploring the Processes of Free Movement Dance as a Physical Therapy Intervention for Female Patients Diagnosed With Chronic Widespread Pain (Including Fibromyalgia). Active, not recruiting
Use of a Bone Substitute Material in the Surgical Therapy of Furcation Defects Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03860805 on ClinicalTrials.gov ↗ ← All trials in Sweden